• 제목/요약/키워드: Atrial Fibrillation

검색결과 358건 처리시간 0.023초

승모판협착증 환자에서 뇌경색발생의 예측인자 (The Predictors of Cerebral Infarction in Mitral Stenosis)

  • 김형준;김웅;이종석;홍그루;박종선;신동구;김영조;심봉섭
    • Journal of Yeungnam Medical Science
    • /
    • 제17권1호
    • /
    • pp.75-81
    • /
    • 2000
  • 저자들은 후향적 연구로 1995년 1월부터 1999년 3월까지 영남대학교 의과대학 부속병원에 내원하여 경흉부 및 경식도 심초음파를 시행한 승모판 협착증 환자 중 1년 이상 경과 관찰된 127명의 환자를 대상으로 뇌경색의 예측인자를 알아봄으로써 향후 예방 및 치료에 도움을 주고자 본 연구를 시행하였다. 전체 127명의 대상군은 뇌경색이 발생한 군(Group I; n=26, 나이: $55.0{\pm}13$세)과 뇌경색이 발생하지 않은 군(Group II: n=101, 나이: $48.5{\pm}13$)으로 나누었으며, 두구간에 성별이나 심부전의 정도(NYHA functional class)에는 의미있는 차이가 없었다. 뇌경색군(Goup I)에서 나이가 많았으며($55.0{\pm}13$ vs $48.5{\pm}13$;p<0.05) 좌심방 크기가 보다 컸으며($5.10{\pm}0.48$ vs $4.81{\pm}0.70$;p<0.05), 승모판구 면적이 보다 작았고($1.01{\pm}0.39$ vs $1.21{\pm}0.45$:p<0.05), 심방세동의 유병률이 보다 높았다(22명/26명 vs 57명/101명;p<0.05). 좌심방의 자발에코 영상은 뇌경색군(22명/26명)에서 비뇌경색군(44명/101명)보다 더 많이 관찰되었다(p<0.001). 상기 의미있는 변수들을 Multivariate logistic regression 분석결과 통계학적으로 유의한 예측인자는 심방세동(R.R=7.69)과 항응고제 치료(R.R=0.23)이었다. 결론적으로, 승모판 협착증 환자에서 뇌경색 발생과 연관된 유의한 예측인자는 심방세동과 항응고제 치료였으며, 나이와 좌심방 크기, 승모판구 면적, 좌심방의 자발에코영상도 밀접한 관계가 있었다. 따라서 심방세동을 동반한 고연령의 중증 승모판 협착증 환자에서는 조기 항응고제 투여가 전신색전증 예방에 주요할 것으로 사료된다.

  • PDF

발작성 심방세동 환자의 P파 간격 측정 방법에 관한 연구 (A Study for measurement method of P-wave duration in Paroxysmal Atrial Fibrillation(PAF) subjects)

  • 이종연;여형석;한완택;김인영;이병채;김준수;민정선;서정돈;이원로
    • 대한의용생체공학회:학술대회논문집
    • /
    • 대한의용생체공학회 1998년도 추계학술대회
    • /
    • pp.181-182
    • /
    • 1998
  • In previous study for correlation between P-wave Signal Averaged Electrocardiography (SAECG) and Paroxysmal Atrial Fibrillation (PAF) subjects, we showed that the duration of P-wave in subjects is longer than in controls. In this respect, the P-wave SAECG is a new method proving to be an accurate and independent noninvasive marker for the risk of PAF. To prove this suggestion, accurate detection and alignment of P-wave are indispensible. In previous study, we measured P-wave duration by manual. So it was not accurate and consistent. To measure the P-wave duration accurately and automatically, we have developed an automatic algorithm for P-wave duration measurement. We showed that the duration of P- wave in the subjects is longer than in controls with this algorithm.

  • PDF

Left Ventricular Ejection Fraction Predicts Poststroke Cardiovascular Events and Mortality in Patients without Atrial Fibrillation and Coronary Heart Disease

  • Lee, Jeong-Yoon;Sunwoo, Jun-Sang;Kwon, Kyum-Yil;Roh, Hakjae;Ahn, Moo-Young;Lee, Min-Ho;Park, Byoung-Won;Hyon, Min Su;Lee, Kyung Bok
    • Korean Circulation Journal
    • /
    • 제48권12호
    • /
    • pp.1148-1156
    • /
    • 2018
  • Background and Objectives: It is controversial that decreased left ventricular function could predict poststroke outcomes. The purpose of this study is to elucidate whether left ventricular ejection fraction (LVEF) can predict cardiovascular events and mortality in acute ischemic stroke (AIS) without atrial fibrillation (AF) and coronary heart disease (CHD). Methods: Transthoracic echocardiography was conducted consecutively in patients with AIS or transient ischemic attack at Soonchunhyang University Hospital between January 2008 and July 2016. The clinical data and echocardiographic LVEF of 1,465 patients were reviewed after excluding AF and CHD. Poststroke disability, major adverse cardiac events (MACE; nonfatal stroke, nonfatal myocardial infarction, and cardiovascular death) and all-cause mortality during 1 year after index stroke were prospectively captured. Cox proportional hazards regressions analysis were applied adjusting traditional risk factors and potential determinants. Results: The mean follow-up time was $259.9{\pm}148.8days$ with a total of 29 non-fatal strokes, 3 myocardial infarctions, 33 cardiovascular deaths, and 53 all-cause mortality. The cumulative incidence of MACE and all-cause mortality were significantly higher in the lowest LVEF (<55) group compared with the others (p=0.022 and 0.009). In prediction models, LVEF (per 10%) had hazards ratios of 0.54 (95% confidence interval [CI], 0.36-0.80, p=0.002) for MACE and 0.61 (95% CI, 0.39-0.97, p=0.037) for all-cause mortality. Conclusions: LVEF could be an independent predictor of cardiovascular events and mortality after AIS in the absence of AF and CHD.

Association Between the Frailty Index and Clinical Outcomes after Coronary Artery Bypass Grafting

  • Kim, Chan Hyeong;Kang, Yoonjin;Kim, Ji Seong;Sohn, Suk Ho;Hwang, Ho Young
    • Journal of Chest Surgery
    • /
    • 제55권3호
    • /
    • pp.189-196
    • /
    • 2022
  • Background: This study investigated the predictive value of the frailty index calculated using laboratory data and vital signs (FI-L) in patients who underwent coronary artery bypass grafting (CABG). Methods: This study included 508 patients (age 67.3±9.7 years, male 78.0%) who underwent CABG between 2018 and 2021. The FI-L, which estimates patients' frailty based on laboratory data and vital signs, was calculated as the ratio of variables outside the normal range for 32 preoperative parameters. The primary endpoints were operative and medium-term all-cause mortality. The secondary endpoints were early postoperative complications and major adverse cardiac and cerebrovascular events (MACCEs). Results: The mean FI-L was 20.9%±10.9%. The early mortality rate was 1.6% (n=8). Postoperative complications were atrial fibrillation (n=148, 29.1%), respiratory complications (n=38, 7.5%), and acute kidney injury (n=15, 3.0%). The 1- and 3-year survival rates were 96.0% and 88.7%, and the 1- and 3-year cumulative incidence rates of MACCEs were 4.87% and 8.98%. In multivariable analyses, the FI-L showed statistically significant associations with medium-term all-cause mortality (hazard ratio [HR], 1.042; 95% confidence interval [CI], 1.010-1.076), MACCEs (subdistribution HR, 1.054; 95% CI, 1.030-1.078), atrial fibrillation (odds ratio [OR], 1.02; 95% CI, 1.002-1.039), acute kidney injury (OR, 1.06; 95% CI, 1.014-1.108), and re-operation for bleeding (OR, 1.09; 95% CI, 1.032-1.152). The minimal p-value approach showed that 32% was the best cutoff for the FI-L as a predictor of all-cause mortality post-CABG. Conclusion: The FI-L was a significant prognostic factor related to all-cause mortality and postoperative complications in patients who underwent CABG.

휴대용 심전도 측정장치를 위한 실시간 QRS-complex 검출 알고리즘 개발 (Development of Real-time QRS-complex Detection Algorithm for Portable ECG Measurement Device)

  • 안휘;심형진;박재순;임종태;정연호
    • 대한의용생체공학회:의공학회지
    • /
    • 제43권4호
    • /
    • pp.280-289
    • /
    • 2022
  • In this paper, we present a QRS-complex detection algorithm to calculate an accurate heartbeat and clearly recognize irregular rhythm from ECG signals. The conventional Pan-Tompkins algorithm brings false QRS detection in the derivative when QRS and noise signals have similar instant variation. The proposed algorithm uses amplitude differences in 7 adjacent samples to detect QRS-complex which has the highest amplitude variation. The calculated amplitude is cubed to dominate QRS-complex and the moving average method is applied to diminish the noise signal's amplitude. Finally, a decision rule with a threshold value is applied to detect accurate QRS-complex. The calculated signals with Pan-Tompkins and proposed algorithms were compared by signal-to-noise ratio to evaluate the noise reduction degree. QRS-complex detection performance was confirmed by sensitivity and the positive predictive value(PPV). Normal ECG, muscle noise ECG, PVC, and atrial fibrillation signals were achieved which were measured from an ECG simulator. The signal-to-noise ratio difference between Pan-Tompkins and the proposed algorithm were 8.1, 8.5, 9.6, and 4.7, respectively. All ratio of the proposed algorithm is higher than the Pan-Tompkins values. It indicates that the proposed algorithm is more robust to noise than the Pan-Tompkins algorithm. The Pan-Tompkins algorithm and the proposed algorithm showed similar sensitivity and PPV at most waveforms. However, with a noisy atrial fibrillation signal, the PPV for QRS-complex has different values, 42% for the Pan-Tompkins algorithm and 100% for the proposed algorithm. It means that the proposed algorithm has superiority for QRS-complex detection in a noisy environment.

R 피크 검출 정확도를 개선한 홀터 심전도 모니터의 개발 (Development of Holter ECG Monitor with Improved ECG R-peak Detection Accuracy)

  • 최정현;강민호;박준호;권기구;배태욱;박준모
    • 융합신호처리학회논문지
    • /
    • 제23권2호
    • /
    • pp.62-69
    • /
    • 2022
  • 의료현장에서는 최근 디지털 헬스케어의 중요성이 대두되면서, 다양한 형태의 생체신호 측정 관련 연구가 활발히 진행되고 있다. 생체신호 중 가장 중요한 신호로 심전도를 들 수 있으며, 특히 부정맥 환자에 있어 심전도 신호의 연속 모니터링은 매우 중요하다. 부정맥은 동결절(sinus node), 동빈맥(sinus tachycardia), 심방조기수축(atrial premature beat, APB), 심실세동 (ventricular fibrillation) 등으로 그 발병원에 따른 형태가 다양하며, 발병 이후의 예후가 좋지 않으므로 일상 중 연속 모니터링은 부정맥의 조기 진단과 치료방향 설정에서 매우 중요하다. 부정맥 환자의 심전도 신호는 매우 불안정하며, 부정맥을 자동 검출하기 위한 주요 특징점으로 작용하는 정확한 R-peak 포인트의 검출이 어렵다. 본 연구에서는 연속 측정하는 홀터 심전도 모니터링 기기와 분석용 소프트웨어를 개발하였으며, 부정맥 데이터베이스를 통해 심전도 신호의 R-peak 효용성을 확인하였다. 향후 연구에서는 다양한 발병원인으로 인한 부정맥의 형태적 구분 및 예측을 위한 알고리즘과 임상 데이터에 근거한 유효성 검증에 관한 추가 연구가 필요하다.

Comparison of Early Complications of Oral Anticoagulants after Totally Thoracoscopic Ablation: Warfarin versus Non-vitamin K Antagonist Oral Anticoagulants

  • MuHyung Heo;Dong Seop Jeong;Suryeun Chung;Kyoung Min Park;Seung Jung Park;Young Keun On
    • Journal of Chest Surgery
    • /
    • 제56권2호
    • /
    • pp.90-98
    • /
    • 2023
  • Background: Atrial fibrillation (AF) is the most common type of cardiac arrhythmia. Totally thoracoscopic ablation (TTA) is a surgical treatment showing a high success rate as a hybrid procedure with radiofrequency catheter ablation to control AF. This study compared the early complications of warfarin and non-vitamin K antagonist oral anticoagulants (NOACs) in patients who underwent TTA. Methods: This single-center retrospective cohort study enrolled patients who underwent planned TTA for AF from February 2012 to October 2020. All patients received postoperative anticoagulation, either with warfarin or a NOAC (apixaban, rivaroxaban, dabigatran, or edoxaban). Propensity score matching was performed for both groups. Early complications were assessed at 12 weeks after TTA and were divided into efficacy and safety outcomes. Both efficacy and safety outcomes were compared in the propensity score-matched groups. Results: Early complications involving efficacy outcomes, such as stroke and transient ischemic attack, were seen in 5 patients in the warfarin group and none in the NOAC group. Although the 2 groups differed in the incidence of efficacy outcomes, it was not statistically significant. In safety outcomes, 11 patients in the warfarin group and 24 patients in the NOAC group had complications, but likewise, the between-group difference was not statistically significant. Conclusion: Among patients who underwent TTA, those who received NOACs had a lower incidence of thromboembolic complications than those who received warfarin; however, both groups showed a similar bleeding complication rate. Using a NOAC after TTA does not reduce efficacy and safety when compared to warfarin.

단독관상동맥우회로술 후 발생한 심방세동 (Postoperative Atrial Fibrillation after Isolated Coronary Artery Bypass Graft Surgery)

  • 서종희;박찬범;문미형;권종범;김영두;진웅;문석환;김치경
    • Journal of Chest Surgery
    • /
    • 제42권1호
    • /
    • pp.14-21
    • /
    • 2009
  • 배경: 심방세동은 관상동맥우회로술후 흔히 발생하는 합병증으로, 대부분 일시적이고 양호한 경과를 보이나, 혈전색전증의 위험성을 증가시키며, 유병률의 증가와 재원기간의 증가로 인하여 의료비용의 증가를 초래할 수 있다. 대상 및 방법: 1994년 1월 1일부터 2007년 12월 31일까지 단독관상동맥우회술을 시행한 190명의 환자 중 수술 후 심방세동이 발생한 군(1군: n=139)과 발생하지 않은 군(2군: n=51)을 나누어 수술 후 심방세동 발생율, 환자의 특성, 수술관련 인자 및 수술 후 심방세동 발생으로 인한 결과를 의무기록을 토대로 후향적으로 분석하였다. 결과: 수술 후 심방세동의 발생율은 26.8%였으며, 퇴원전까지 정상동방결절리듬으로 회복된 경우는 82.4%였고, 심방세동 발생 환자의 82.4%는 수술 후 3일 이내에 발생하였다. 술후 심방세동군에서는 나이가 유의하게 많았으며, 대동맥겸자 차단시간의 차이는 없었으나, 대동맥 겸차차단 해제시 자발적으로 정상 심전도를 회복하지 못한 경우가 많았으며, 체외순환시간이 더 긴 것으로 나타났다. 수술후 베타차단제의 사용이 심방세동의 발생을 감소시키는 것으로 나타났으며, 재원기간의 차이는 없었으나, 중환자실 체류기간은 심방세동군에서 유의하게 길었다. 다변량 분석에서는 연령, 대동맥겸차 해제후 자발적 심박동 회복여부, 중환자실 재원기간 및 술후 베타 차단제의 사용이 유의한 인자로 분석되었다. 결론: 관상동맥우회로술후 심방세동은 매우 흔한 합병증으로 유병률이 증가되며, 중환자실 재원기간의 증가를 초래한다. 따라서, 술후 심방세동의 발생을 예방하기 위한 조치들이 필요할 것으로 생각되며, 특별한 금기사항이 없다면, 술후 베타 차단제를 적극적으로 사용하는 것이 좋을 것으로 생각된다.

Quality of Anticoagulation and Treatment Satisfaction in Patients with Non-Valvular Atrial Fibrillation Treated with Vitamin K Antagonist: Result from the KORean Atrial Fibrillation Investigation II

  • Oh, Seil;Kim, June-Soo;Oh, Yong-Seog;Shin, Dong-Gu;Pak, Hui-Nam;Hwang, Gyo-Seung;Choi, Kee-Joon;Kim, Jin-Bae;Lee, Man-Young;Park, Hyung-Wook;Kim, Dae-Kyeong;Jin, Eun-Sun;Park, Jaeseok;Oh, Il-Young;Shin, Dae-Hee;Park, Hyoung-Seob;Kim, Jun Hyung;Kim, Nam-Ho;Ahn, Min-Soo;Seo, Bo-Jeong;Kim, Young-Joo;Kang, Seongsik;Lee, Juneyoung;Kim, Young-Hoon
    • Journal of Korean Medical Science
    • /
    • 제33권49호
    • /
    • pp.323.1-323.12
    • /
    • 2018
  • Background: Vitamin K antagonist (VKA) to prevent thromboembolism in non-valvular atrial fibrillation (NVAF) patients has limitations such as drug interaction. This study investigated the clinical characteristics of Korean patients treated with VKA for stroke prevention and assessed quality of VKA therapy and treatment satisfaction. Methods: We conducted a multicenter, prospective, non-interventional study. Patients with $CHADS_2{\geq}1$ and treated with VKA (started within the last 3 months) were enrolled from April 2013 to March 2014. Demographic and clinical features including risk factors of stroke and VKA treatment information was collected at baseline. Treatment patterns and international normalized ratio (INR) level were evaluated during follow-up. Time in therapeutic range (TTR) > 60% indicated well-controlled INR. Treatment satisfaction on the VKA use was measured by Treatment Satisfaction Questionnaire for Medication (TSQM) after 3 months of follow-up. Results: A total of 877 patients (age, 67; male, 60%) were enrolled and followed up for one year. More than half of patients (56%) had $CHADS_2{\geq}2$ and 83.6% had $CHA_2DS_2-VASc{\geq}2$. A total of 852 patients had one or more INR measurement during their follow-up period. Among those patients, 25.5% discontinued VKA treatment during follow-up. Of all patients, 626 patients (73%) had poor-controlled INR (TTR < 60%) measure. Patients' treatment satisfaction measured with TSQM was 55.6 in global satisfaction domain. Conclusion: INR was poorly controlled in Korean NVAF patients treated with VKA. VKA users also showed low treatment satisfaction.

좌심방 확장을 동반한 심방세동에 대한 Cox-Maze 수술법의 변형 -수술후 좌심방 수축력의 증진을 위한 수술법의 개량- (Modification of the Cox-Maze Procedure for Atrial Fibrillation with Large Left Atrium ; Development of Surgical Technique to Increase the Left Atrial Contractility)

  • 강창현;김기봉;손대원
    • Journal of Chest Surgery
    • /
    • 제32권3호
    • /
    • pp.249-254
    • /
    • 1999
  • 배경: Cox-Maze 술식후의 좌심방의 수축력은 우심방에 비하여 회복률이 낮은 것으로 알려져 있다. 술전 좌심방의 크기가 큰 환자군에서의 Cox-Maze 술식은, 좌심방 후벽의 많은 부위를 전기전도계와 분리함으로써 술후 좌심방 기능의 회복을 저하시키는 한 요인이 될 수 있다. 본 연구자들은 좌심방이 심하게 확장된 경우에 좌, 우 폐정맥을 각각 분리하는 변형된 Cox-Maze 술식을 시행함으로써 이러한 술식이 술후 좌심방 기능의 회복에 도움을 주는지 여부에 대해 알아보고자 하였다. 대상 및 방법: 1995년 2월부터 1997년 10월까지 승모판막 질환과 동반된 심방세동으로 Cox-Maze 술식을 시행한 환자들 중, 수술후 6개월 이상의 추적관찰이 이루어지고 동율동 전환이 이루어진 환자를 대상으로 하였다. I군은 좌, 우 폐정맥사이의 거리가 6.5cm미만인 경우(n=30), II군은 좌, 우 폐정맥사이의 거리가 6.5cm 이상인 경우(n=16)로서 I, II군은 좌,우 폐정맥을 함께 분리하는 기존의 Cox-Maze 술식을 시행하였고, III군은 폐정맥사이의 거리가 6.5cm이상인 경우에 좌, 우 폐정맥을 각각 분리하는 변형된 Cox-Maze 술식을 사용하였다(n=9). 결과:각 군사이에는 좌심방 크기를 제외한 검사소견은 차이가 없었으며 III군의 경우 수술시 대동맥차단 시간이 유의하게 증가되었다(p<0.05). 술후 장기 추적 검사상 우심방의 수축력 회복은 I군에서 90%, II군에서 81%, 그리고 III군에서 100%에서 회복됨이 관찰되었다. 좌심방의 수축력회복은 I군에서 63%, II군에서 31%에서 회복되어 좌심방이 확장된 II군에서 유의한 감소가 있었으며 (p<0.04), III군에서는 66%에서 회복되었으나 I, II군과 유의한 차이는 없었다. 결론:이러한 양폐정맥 사이를 분리, 절개하는 변형된 Cox-Maze 술식은 좌심방 수축력의 회복에 긍정적인 영향을 미칠 것으로 추정되며, 향후 더 많은 환자군에서 연구가 시행되어야 하리라 사료된다.

  • PDF